Cargando…
P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN-LABEL DOSE ESCALATION STUDY
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429319/ http://dx.doi.org/10.1097/01.HS9.0000849812.21433.44 |
| _version_ | 1784779403648040960 |
|---|---|
| author | van de Donk, N. W. Guo, S. Shi, L. Lord-Bessen, J. Tang, D. Karlin, L. Weisel, K. Ramasamy, K. Abad, P. C. Amin, A. Amin, S. Lonial, S. |
| author_facet | van de Donk, N. W. Guo, S. Shi, L. Lord-Bessen, J. Tang, D. Karlin, L. Weisel, K. Ramasamy, K. Abad, P. C. Amin, A. Amin, S. Lonial, S. |
| author_sort | van de Donk, N. W. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429319 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94293192022-08-31 P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN-LABEL DOSE ESCALATION STUDY van de Donk, N. W. Guo, S. Shi, L. Lord-Bessen, J. Tang, D. Karlin, L. Weisel, K. Ramasamy, K. Abad, P. C. Amin, A. Amin, S. Lonial, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429319/ http://dx.doi.org/10.1097/01.HS9.0000849812.21433.44 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters van de Donk, N. W. Guo, S. Shi, L. Lord-Bessen, J. Tang, D. Karlin, L. Weisel, K. Ramasamy, K. Abad, P. C. Amin, A. Amin, S. Lonial, S. P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN-LABEL DOSE ESCALATION STUDY |
| title | P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN-LABEL DOSE ESCALATION STUDY |
| title_full | P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN-LABEL DOSE ESCALATION STUDY |
| title_fullStr | P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN-LABEL DOSE ESCALATION STUDY |
| title_full_unstemmed | P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN-LABEL DOSE ESCALATION STUDY |
| title_short | P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN-LABEL DOSE ESCALATION STUDY |
| title_sort | p1739: health-related quality of life in patients with triple-class exposed relapsed/refractory multiple myeloma treated with iberdomide plus dexamethasone in a phase 1b/2a open-label dose escalation study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429319/ http://dx.doi.org/10.1097/01.HS9.0000849812.21433.44 |
| work_keys_str_mv | AT vandedonknw p1739healthrelatedqualityoflifeinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomatreatedwithiberdomideplusdexamethasoneinaphase1b2aopenlabeldoseescalationstudy AT guos p1739healthrelatedqualityoflifeinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomatreatedwithiberdomideplusdexamethasoneinaphase1b2aopenlabeldoseescalationstudy AT shil p1739healthrelatedqualityoflifeinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomatreatedwithiberdomideplusdexamethasoneinaphase1b2aopenlabeldoseescalationstudy AT lordbessenj p1739healthrelatedqualityoflifeinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomatreatedwithiberdomideplusdexamethasoneinaphase1b2aopenlabeldoseescalationstudy AT tangd p1739healthrelatedqualityoflifeinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomatreatedwithiberdomideplusdexamethasoneinaphase1b2aopenlabeldoseescalationstudy AT karlinl p1739healthrelatedqualityoflifeinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomatreatedwithiberdomideplusdexamethasoneinaphase1b2aopenlabeldoseescalationstudy AT weiselk p1739healthrelatedqualityoflifeinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomatreatedwithiberdomideplusdexamethasoneinaphase1b2aopenlabeldoseescalationstudy AT ramasamyk p1739healthrelatedqualityoflifeinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomatreatedwithiberdomideplusdexamethasoneinaphase1b2aopenlabeldoseescalationstudy AT abadpc p1739healthrelatedqualityoflifeinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomatreatedwithiberdomideplusdexamethasoneinaphase1b2aopenlabeldoseescalationstudy AT amina p1739healthrelatedqualityoflifeinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomatreatedwithiberdomideplusdexamethasoneinaphase1b2aopenlabeldoseescalationstudy AT amins p1739healthrelatedqualityoflifeinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomatreatedwithiberdomideplusdexamethasoneinaphase1b2aopenlabeldoseescalationstudy AT lonials p1739healthrelatedqualityoflifeinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomatreatedwithiberdomideplusdexamethasoneinaphase1b2aopenlabeldoseescalationstudy |